GoodRx Holdings, Inc. (GDRX)
NASDAQ: GDRX · Real-Time Price · USD
4.200
-0.110 (-2.55%)
Nov 21, 2024, 11:52 AM EST - Market open
GoodRx Holdings Market Cap
GoodRx Holdings has a market cap or net worth of $1.62 billion as of November 21, 2024. Its market cap has decreased by -25.34% in one year.
Market Cap
1.62B
Enterprise Value
1.78B
1-Year Change
-25.34%
Ranking
Category
Stock Price
$4.20
Market Cap Chart
Since the IPO on September 23, 2020, GoodRx Holdings's market cap has decreased from $12.67B to $1.62B, a decrease of -87.25%. That is a compound annual growth rate of -39.05%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 19, 2024 | 1.63B | -40.04% |
| Dec 29, 2023 | 2.72B | 47.38% |
| Dec 30, 2022 | 1.85B | -85.84% |
| Dec 31, 2021 | 13.04B | -17.43% |
| Dec 31, 2020 | 15.79B | 24.57% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Fortrea Holdings | 1.68B |
| Celldex Therapeutics | 1.66B |
| Xencor | 1.65B |
| 10x Genomics | 1.64B |
| Clover Health Investments | 1.64B |
| Immunocore Holdings | 1.63B |
| Nurix Therapeutics | 1.61B |
| Viridian Therapeutics | 1.60B |